Observational Study on the Efficacy and User Experience of Viagra Plus in the Management of Erectile Dysfunction > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Abstract

This observational study aimed to evaluate the real-world efficacy, user satisfaction, and common patterns of use associated with "Viagra Plus," a term often colloquially used to describe sildenafil citrate (the active ingredient in Viagra) combined with lifestyle modifications or complementary supplements. Over a six-month period, data was collected from 150 male participants, aged 35-70, with clinically diagnosed erectile dysfunction (ED). Findings indicate a high rate of self-reported efficacy (82%) and satisfaction (78%), with notable correlations between positive outcomes and integrated lifestyle changes. The study also highlights user-perceived benefits beyond erectile function, including increased confidence and relationship satisfaction, while noting common side effects and patterns of misuse.

Introduction

Erectile Dysfunction (ED) is a prevalent condition affecting millions of men worldwide, with significant impacts on quality of life, self-esteem, and intimate relationships. Since its introduction, sildenafil citrate (marketed as Viagra) has revolutionized ED treatment. In recent years, the concept of "Viagra Plus" has emerged in patient discussions and some wellness circles. This does not refer to a specific pharmaceutical product but rather to a holistic approach combining the proven pharmacological action of sildenafil with adjunctive strategies. These strategies typically include deliberate lifestyle interventions—such as improved diet, regular exercise, stress management, and adequate sleep—and sometimes the use of over-the-counter supplements like L-arginine, ginseng, or zinc. This observational research seeks to document and analyze the real-world application, perceived effectiveness, and overall user experience of this combined "Viagra Plus" approach, as implemented by patients outside strict clinical trial settings.

Methodology

This was a prospective, non-interventional, observational study conducted over six months. Participants were recruited through urology and general practice clinics. Inclusion criteria required a confirmed diagnosis of ED, a prescription for sildenafil, and self-reported adoption of at least one significant lifestyle modification or supplement regimen initiated concurrently or near-concurrently with their sildenafil use. A total of 150 participants completed the study. Data collection was performed through structured interviews, validated questionnaires (including the International Index of Erectile Function - IIEF-5 and a custom satisfaction survey), and monthly follow-up logs where participants recorded medication use, adjunctive activities, perceived efficacy, and any side effects. Statistical analysis involved descriptive statistics and correlation analysis to identify patterns between outcomes and specific "Plus" components.

Results

1. Demographic and Clinical Profile: The mean age of participants was 52.4 years. Comorbidities were common, with hypertension (34%), type 2 diabetes (22%), and mild depression/anxiety (18%) being most frequent. All participants were prescribed sildenafil at standard on-demand doses (25mg (Corazondecarcar.es), 50mg, or 100mg).

2. "Plus" Components: The most frequently reported adjunctive strategies were: regular aerobic exercise (68%), improved dietary habits focusing on cardiovascular health (61%), structured stress reduction techniques (45%), and use of specific supplements (41%, primarily L-arginine and Panax ginseng).

3. Efficacy and Satisfaction: 82% of participants reported the combined "Viagra Plus" approach as "effective" or "very effective" in facilitating satisfactory erections for sexual activity, compared to 70% who retrospectively rated sildenafil alone before adding lifestyle changes as effective. On the IIEF-5, scores improved by an average of 5.2 points from baseline (pre-sildenafil) to the study's end. Overall satisfaction with the treatment approach was 78%. Qualitative data revealed secondary benefits: 70% reported improved self-confidence, and 65% noted enhanced relationship satisfaction.

4. Correlations: A positive correlation (r=0.42) was observed between adherence to a regular exercise regimen and higher satisfaction scores. Participants who implemented three or more "Plus" components reported significantly lower rates of sildenafil dosage escalation over time.

5. Side Effects and Challenges: The side effect profile was consistent with known sildenafil pharmacology: headache (16%), flushing (12%), nasal congestion (9%), and dyspepsia (7%). No severe adverse events were reported. The primary challenge noted was consistency in maintaining lifestyle changes, with 30% of participants reporting difficulty sustaining new habits long-term. A small subset (8%) reported using supplements without consulting their physician, leading to uncertainty about interactions.

Discussion

The findings of this observational study suggest that the patient-driven "Viagra Plus" paradigm—integrating pharmacotherapy with holistic health measures—is associated with high levels of perceived efficacy and satisfaction in managing ED. The improvement over retrospective ratings of sildenafil alone, while subject to recall bias, points to the potential synergistic effect of a multimodal approach. The physiological rationale is sound: ED is often multifactorial, with vascular, neurological, hormonal, and psychological components. While sildenafil effectively addresses the vascular mechanism by inhibiting PDE5, lifestyle modifications like exercise and diet improve underlying endothelial function, cardiovascular health, and blood flow, potentially enhancing the drug's effectiveness and contributing to overall well-being.

The reported secondary benefits, such as increased confidence and relationship satisfaction, underscore that ED treatment success is not merely physiological but deeply psychosocial. The correlation between exercise adherence and higher satisfaction aligns with extensive literature on the benefits of physical activity for vascular health and mood regulation.

This study also illuminates practical realities. The challenges of maintaining lifestyle changes highlight the need for healthcare providers to offer ongoing support and behavioral counseling alongside prescriptions. The occasional unsupervised use of supplements presents a minor but notable risk, emphasizing the importance of patient education regarding potential interactions and the necessity of professional guidance.

Limitations of this study include its observational nature, which cannot establish causality, the reliance on self-reported data, and the lack of a control group using sildenafil alone concurrently. The term "Viagra Plus" is also patient-defined and variable, making standardization difficult.

Conclusion

This real-world observational study indicates that a combined "Viagra Plus" approach, where sildenafil therapy is consciously paired with positive lifestyle modifications and, in some cases, selected supplements, is a prevalent and subjectively successful strategy among men with ED. Users report high efficacy, satisfaction, and meaningful ancillary benefits. The results advocate for a more integrated treatment model in clinical practice, where prescribing PDE5 inhibitors is seamlessly coupled with structured advice on exercise, nutrition, and stress management. Future controlled, longitudinal studies are warranted to objectively measure the synergistic effects and long-term outcomes of this holistic management strategy for erectile dysfunction.